Clinical Trial Update: MSC for Treatment of cGVHD After Allo-HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for mesenchymal stem cells aimed at treating chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• MSC

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Chronic Graft-versus-host Disease | Phase 2 | Status: UNKNOWN